Clinical Trials at Carolina BioOncology Institute
As of June 2026, 24 paid clinical trials are recruiting at Carolina BioOncology Institute, located at 9801 KINCEY AVE, SUITE 145, HUNTERSVILLE, NC 28078-3110, phone (704) 947-6599 in Huntersville, North Carolina. Active studies at this site cover conditions such as Advanced Solid Tumors, Idiopathic Hypersomnia and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
24 clinical trials at Carolina BioOncology Institute
·Clear filters·↓ Download CSVA Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
A Study of HS-20110 in Participants With Advanced Solid Tumors
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
About research studies in Huntersville
Huntersville has approximately 80 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Common conditions studied in Huntersville
- Advanced Solid Tumors (6 active studies). Recruiting Advanced Solid Tumors studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Idiopathic Hypersomnia (6 active studies). Recruiting Idiopathic Hypersomnia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Solid Tumor (5 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Narcolepsy Type 1 (5 active studies). Recruiting Narcolepsy Type 1 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Narcolepsy Type 2 (5 active studies). Recruiting Narcolepsy Type 2 studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Solid Tumor, Adult (5 active studies). Recruiting Solid Tumor, Adult studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Huntersville
- AbbVie
- Alliance for Clinical Trials in Oncology
- AstraZeneca
- Centessa Pharmaceuticals (UK) Limited
- NRG Oncology
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Huntersville. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Huntersville
Hipa.ai aggregates every recruiting study in Huntersville from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Huntersville?
There are approximately 80 recruiting clinical trials in Huntersville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Huntersville pay participants?
Most recruiting trials in Huntersville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Huntersville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Huntersville?
The most common conditions under active study in Huntersville include Advanced Solid Tumors (6), Idiopathic Hypersomnia (6), Advanced Solid Tumor (5), Narcolepsy Type 1 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Huntersville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Huntersville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Huntersville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Huntersville?
Recruiting research sites in Huntersville include Carolina BioOncology Institute, Novant Health Cancer Institute - Huntersville, Novant Health Presbyterian Medical Center Huntersville, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Huntersville right now?
The largest active categories in Huntersville are Cancer & tumors (41), Neurology & pain (2), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Carolina BioOncology Institute?
Carolina BioOncology Institute is located at 9801 KINCEY AVE, SUITE 145, HUNTERSVILLE, NC 28078-3110. Use the Google Maps link in the intro above to get directions.
How do I contact Carolina BioOncology Institute?
You can reach Carolina BioOncology Institute by phone at (704) 947-6599. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.